Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ADC Antibody
    (1)
  • Antibody-Drug Conjugates (ADCs)
    (1)
TargetMol | Tags By Application
  • ELISA
    (2)
  • Functional assay
    (2)
  • FACS
    (1)
  • FCM
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

lupartumab

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • ADC/ADC Related
    2
    TargetMol | All_Pathways
  • Lupartumab
    BAY 1112623
    T774121640971-88-5
    Lupartumab (BAY 1112623) is a monoclonal antibody targeting LYPD3 (C4.4A) and is employed in the synthesis of antibody-active molecular couplers for studying LYPD3-associated tumor diseases.
    • $297
    In Stock
    Size
    QTY
  • Lupartumab Amadotin
    BAY 1129980, Anti-C4.4a antibody-drug conjugates
    T9901A-10231640972-00-4
    Lupartumab Amadotin (BAY 1129980) is an antibody-drug conjugate (ADC) composed of a fully human C4.4A (LYPD3) targeting monoclonal antibody (BAY 1135626) linked through a non-cleavable alkyl hydrazide linker to a novel, highly potent microtubule-disrupting cytotoxic auristatin derivative. Lupartumab Amadotin is utilized in research on non-small cell lung cancer.
    • Inquiry Price
    Inquiry
    Size
    QTY